OOIR: Observatory of International Research

Papers

(The H4-Index of Thrombosis Research is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Is all collagen the same for platelet testing? Editorial on “Platelet collagen receptors and their role in modulating platelet adhesion patterns and activation on alternatively processed collagen subs	76
Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease	71
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban	56
Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]	56
A novel role of acellular hemoglobin in hemolytic thrombosis	45
Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease: TTR and INR variability	44
PO-08: Characterisation of plasma extracellular vesicles in myeloproliferative neoplasms	41
Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination	41
PO-51: Kaposiform hemangioendothelioma is associated with platelet functional abnormalities that persist in patients even after complete blood cell count recovery	41
Crosstalk between hemostasis and immunity in cancer pathogenesis	40
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis	39
Linezolid impair proplatelet formation by reducing mitochondrial energy metabolism in MEG-01 cells	37
Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors	34
PO-39: Superior vena cava stenting: an effective and safe therapeutic choice for the treatment of superior vena cava syndrome in lung cancer patients	33
Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers	32
DOACs: A perfect fit for patients with bariatric surgery?	32
Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study	31
Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms	30
Unveiling the predictive capacity of inflammatory and platelet markers for central retinal artery occlusion	29
Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors	29
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study	28
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice	28
Regulation of fibrinogen synthesis	28
Investigation of the impact of antithrombin deficiency on the inflammatory response: Results from a single centre cohort study	28
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients	28

Editorial Board	28
Distinct Immunologic Mediators Are Associated with Venous Thromboembolism in Multiply Injured Patients	28